Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23729)

Formulation Name
Elagolix Sodium 150 mg tablet
Company
Abbvie
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Elagolix sodium DMRDUC0 Endometriosis GA10 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmine E00622 Not Available Colorant
Magnesium stearate E00208 11177 lubricant
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 4000 E00654 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Pregelatinized starch E00674 Not Available Binding agent; Diluent; Disintegrant
Sodium carbonate monohydrate E00454 2735133 Alkalizing agent; Buffering agent; Diluent; Dispersing agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent